Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Matthew C. Miller; Mary Ann Forciea; Linda L. Humphrey; Mary Ann Forciea; Linda L. Humphrey; Adam J. Obley; Andrew Dunn; Robert M. Centor; Elie A. Akl; Thomas A. Bledsoe; Mary Ann Forciea; Ray Haeme; Janet A. Jokela; Devan L. Kansagara; Maura Marcucci; Mark P. Tschanz

doi:10.7326/L21-0607

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem^*, Jennifer Yost, Itziar Etxeandia-Ikobaltzeta, George M. Abraham, Janet A. Jokela, Matthew C. Miller, Mary Ann Forciea, Linda L. Humphrey, Mary Ann Forciea, Linda L. Humphrey, Adam J. Obley, Andrew Dunn, Robert M. Centor, Elie A. Akl, Thomas A. Bledsoe, Mary Ann Forciea, Ray Haeme, Janet A. Jokela, Devan L. Kansagara, Maura MarcucciMark P. Tschanz

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	W116-W117
Journal	Annals of Internal Medicine
Volume	174
Issue number	12
DOIs	https://doi.org/10.7326/L21-0607
State	Published - 1 Dec 2021

Access to Document

10.7326/L21-0607

Cite this

Qaseem, A., Yost, J., Etxeandia-Ikobaltzeta, I., Abraham, G. M., Jokela, J. A., Miller, M. C., Forciea, M. A., Humphrey, L. L., Forciea, M. A., Humphrey, L. L., Obley, A. J., Dunn, A., Centor, R. M., Akl, E. A., Bledsoe, T. A., Forciea, M. A., Haeme, R., Jokela, J. A., Kansagara, D. L., ... Tschanz, M. P. (2021). Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Annals of Internal Medicine, 174(12), W116-W117. https://doi.org/10.7326/L21-0607

@article{15c854544d4849e4bd1476ed2ffaf777,

title = "Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)",

author = "Amir Qaseem and Jennifer Yost and Itziar Etxeandia-Ikobaltzeta and Abraham, {George M.} and Jokela, {Janet A.} and Miller, {Matthew C.} and Forciea, {Mary Ann} and Humphrey, {Linda L.} and Forciea, {Mary Ann} and Humphrey, {Linda L.} and Obley, {Adam J.} and Andrew Dunn and Centor, {Robert M.} and Akl, {Elie A.} and Bledsoe, {Thomas A.} and Forciea, {Mary Ann} and Ray Haeme and Jokela, {Janet A.} and Kansagara, {Devan L.} and Maura Marcucci and Tschanz, {Mark P.}",

year = "2021",

month = dec,

day = "1",

doi = "10.7326/L21-0607",

language = "English",

volume = "174",

pages = "W116--W117",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

number = "12",

}

Qaseem, A, Yost, J, Etxeandia-Ikobaltzeta, I, Abraham, GM, Jokela, JA, Miller, MC, Forciea, MA, Humphrey, LL, Forciea, MA, Humphrey, LL, Obley, AJ, Dunn, A, Centor, RM, Akl, EA, Bledsoe, TA, Forciea, MA, Haeme, R, Jokela, JA, Kansagara, DL, Marcucci, M & Tschanz, MP 2021, 'Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)', Annals of Internal Medicine, vol. 174, no. 12, pp. W116-W117. https://doi.org/10.7326/L21-0607

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). / Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar et al.
In: Annals of Internal Medicine, Vol. 174, No. 12, 01.12.2021, p. W116-W117.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Update Alert 2

T2 - Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

AU - Qaseem, Amir

AU - Yost, Jennifer

AU - Etxeandia-Ikobaltzeta, Itziar

AU - Abraham, George M.

AU - Jokela, Janet A.

AU - Miller, Matthew C.

AU - Forciea, Mary Ann

AU - Humphrey, Linda L.

AU - Forciea, Mary Ann

AU - Humphrey, Linda L.

AU - Obley, Adam J.

AU - Dunn, Andrew

AU - Centor, Robert M.

AU - Akl, Elie A.

AU - Bledsoe, Thomas A.

AU - Forciea, Mary Ann

AU - Haeme, Ray

AU - Jokela, Janet A.

AU - Kansagara, Devan L.

AU - Marcucci, Maura

AU - Tschanz, Mark P.

PY - 2021/12/1

Y1 - 2021/12/1

UR - http://www.scopus.com/inward/record.url?scp=85122904196&partnerID=8YFLogxK

U2 - 10.7326/L21-0607

DO - 10.7326/L21-0607

M3 - Letter

C2 - 34606308

AN - SCOPUS:85122904196

SN - 0003-4819

VL - 174

SP - W116-W117

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 12

ER -

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Access to Document

Fingerprint

Cite this